Early Clinical Improvement as Predictor of Long-Term Health-Related Quality of Life in Psoriatic Arthritis Patients Treated With Guselkumab: Post Hoc Analysis Through 2 Years of a Phase 3 Study

被引：0
|
作者：
McInnes, Iain [1 ]
Soriano, Enrique [2 ,3 ]
Tam, Lai-Shan
Bessette, Louis [4 ,5 ]
Shiff, Natalie [6 ]
Shawi, May [7 ]
Rampakakis, Emmanouil [8 ]
Curtis, Jeffrey [9 ]
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Inst Univ, Hosp Italiano Buenos Aires, Dept Publ Hlth, Escuela Med, Buenos Aires, DF, Argentina
[3] Hosp Italiano Buenos Aires, Rheumatol Unit, Internal Med Serv, Buenos Aires, DF, Argentina
[4] Univ Laval, Laval, PQ, Canada
[5] CHU Quebec, Laval, PQ, Canada
[6] Univ Florida, Gainesville, FL USA
[7] Janssen Inc, Raritan, NJ USA
[8] JSS Med Res Inc, Montreal, PQ, Canada
[9] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF RHEUMATOLOGY | 2023年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
88
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [1] Early Clinical Improvement as Predictor of Long-term Health-Related Quality of Life in Psoriatic Arthritis Patients Treated with Guselkumab: Post Hoc Analysis Through 2 Years of a Phase 3 Study
    McInnes, Iain B.
    Soriano, Enrique R.
    Tam, Lai-Shan
    Shiff, Natalie
    Shawi, May
    Rampakakis, Emmanouil
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4184 - 4187
  • [2] EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY
    Mcinnes, I.
    Soriano, E.
    Tam, L. S.
    Shiff, N.
    Shawi, M.
    Rampakakis, E.
    Curtis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1765 - 1766
  • [3] EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY
    Coates, L.
    Ramirez, J.
    Mcgonagle, D.
    Aydin, S.
    Zimmermann, M.
    Nantel, F.
    Shawi, M.
    Rampakakis, E.
    Nash, P.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1137 - 1137
  • [4] Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Post Hoc Analysis Through 2 Years of a Phase 3 Study
    Coates, Laura
    Ramirez, Julio
    McGonagle, Dennis
    Aydin, Sibel
    Zimmermann, Miriam
    Nantel, Francois
    Shawi, May
    Rampakakis, Emmanouil
    Nash, Peter
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4187 - 4189
  • [5] EARLY CLINICAL RESPONSE AS A PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS AND TNFI-IR RECEIVING GUSELKUMAB (COSMOS)
    Gossec, L.
    Aletaha, D.
    Sewerin, P.
    Zabotti, A.
    Van den Bosch, F.
    Efficace, M.
    Lavie, F.
    Zimmermann, M.
    Sharaf, M.
    Mcinnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1761 - 1761
  • [6] GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 2 YEARS OF DISCOVER-2
    Curtis, J.
    McInnes, I.
    Rahman, P.
    Gladman, D. D.
    Yang, F.
    Peterson, S.
    Kollmeier, A.
    Shiff, N.
    Han, C.
    Shawi, M.
    Tillett, W.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1563 - 1564
  • [7] Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
    Curtis, Jeffrey
    McInnes, Iain B.
    Rahman, Proton
    Gladman, Dafna
    Yang, Feifei
    Peterson, Steve
    Kollmeier, Alexa
    Shiff, Natalie
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3651 - 3653
  • [8] LONG-TERM IMPROVEMENT IN INDIVIDUAL ACR RESPONSE CRITERIA AND RESIDUAL DISEASE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST HOC ANALYSIS OF A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY
    Nash, P.
    Mcinnes, I.
    Shawi, M.
    Nantel, F.
    Kollmeier, A.
    Rampakakis, E.
    Soriano, E.
    Gladman, D. D.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1769 - 1770
  • [9] Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Pooled Post Hoc Analyses Through 1 Year of Two Phase 3 Studies
    Coates, Laura C.
    Ramirez, Julio
    McGonagle, Dennis
    Aydin, Sibel
    Zimmermann, Miriam
    Nantel, Francois
    Shawi, May
    Rampakakis, Emmanouil
    Nash, Peter
    Mease, Philip
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB152 - AB152
  • [10] Relationships Between Dermatologic Symptoms and Health-related Quality of Life in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Taylor, Peter C.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Young, Pamela
    Germino, Rebecca
    Merola, Joseph
    Yosipovitch, Gil
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3803 - 3805
12345